歐慶健，男，同濟大學醫學院助理教授。主要研究人誘導多能幹細胞（iPSCs）在年齡相關性疾病中的套用與治療，重點關注眼部年齡相關性黃斑變性（AMD）的幹細胞替代治療。建立人iPSC來源視網膜色素上皮（RPE）細胞的治療體系，進入臨床轉化階段。主持上海市衛健委臨床研究專項1項和國家自然科學基金項目1項。
人物經歷,主要成就,
人物經歷
歐慶健，男，同濟大學醫學院助理教授。主要研究人誘導多能幹細胞（iPSCs）在年齡相關性疾病中的套用與治療，重點關注眼部年齡相關性黃斑變性（AMD）的幹細胞替代治療。建立人iPSC來源視網膜色素上皮（RPE）細胞的治療體系，進入臨床轉化階段。主持上海市衛健委臨床研究專項1項和國家自然科學基金項目1項。
主要成就
【近通訊/一作發表論文7篇】
（1）Bioinformatics-integrated screening of systemic sclerosis-specific expressed markers to identify therapeutic targets; Frontiers in Immunology; 2023
（2）The increased cfRNA of TNFSF4 in peripheral blood at late gestation and preterm labor: its implication as a noninvasive biomarker for premature delivery; Frontiers in Immunology; 2023
（3）Subconjunctival injection of human umbilical cord mesenchymal stem cells alleviates experimental allergic conjunctivitis via regulating T cell response; Stem Cell Research & Therapy; 2023
（4）Asparagine alleviates naphthalene-induced lens opacity by suppressing ferroptosis; Experimental Eye Research; 2025
（5）miR-143-3p boosts extracellular vesicles to improve the dermal fibrosis of localized scleroderma; Journal of Autoimmunity;2025
（6）PHOSPHO1 Suppresses Ferroptosis in Retinal Pigment Epithelial Cells by Reducing the Levels of Phosphatidylethanolamine Molecular Species; Advanced Science;2025
（7）Naphthalene Metabolites From Long‐Term Environmental Tobacco Smoke Induce the Aging of Retinal Pigment Epithelium; Aging Cell;2025
